Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-13

Clinical Trial Update: A Pilot Study of Hemoporfin PDT in Children With Port-wine Stain [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluating Hemoporfin photodynamic therapy in children with port-wine stain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hemoporfin PDT (hematoporphyrin derivative (Hemoporfin) used in photodynamic therapy)

Snippet

Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Conditions: Port-wine Stain | Phase 4 | Status: COMPLETED